MUSILLI, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 855
EU - Europa 838
AS - Asia 137
AF - Africa 2
Totale 1.832
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 853
PL - Polonia 529
IT - Italia 85
SE - Svezia 83
IE - Irlanda 73
CN - Cina 51
HK - Hong Kong 37
FI - Finlandia 18
SG - Singapore 18
TR - Turchia 15
GB - Regno Unito 13
BE - Belgio 9
DE - Germania 9
RU - Federazione Russa 7
UA - Ucraina 7
JO - Giordania 6
VN - Vietnam 4
CA - Canada 2
CH - Svizzera 2
IN - India 2
KR - Corea 2
SC - Seychelles 2
FR - Francia 1
KZ - Kazakistan 1
MM - Myanmar 1
NL - Olanda 1
PT - Portogallo 1
Totale 1.832
Salva come PNG Salva come JPEG
Città #
Warsaw 528
Fairfield 113
Chandler 109
Dublin 73
Seattle 70
Ann Arbor 67
Ashburn 67
Woodbridge 60
Houston 41
Cambridge 40
Wilmington 39
Beijing 22
Florence 20
Hong Kong 20
Princeton 20
Altamura 19
Lawrence 19
Jacksonville 13
Medford 13
Singapore 12
Shanghai 11
Boston 9
Brussels 9
Kent 9
Boardman 8
Buffalo 7
San Diego 6
Norwalk 5
Rome 5
Dong Ket 4
Phoenix 4
Dearborn 3
Izmir 3
Milan 3
Bern 2
Catania 2
Kanpur 2
Marcallo con Casone 2
Naples 2
New York 2
Redwood City 2
Toronto 2
Angri 1
Arezzo 1
Centrale 1
Comiso 1
Dallas 1
Elkins Park 1
Faro 1
Giungano 1
Grevenbroich 1
Hebei 1
Jiaxing 1
Jinan 1
Lequile 1
Lodi 1
London 1
Nanjing 1
New Bedfont 1
Pannarano 1
Pisa 1
Priola 1
Redmond 1
Saviano 1
Scarperia 1
Shenyang 1
Tianjin 1
Yangon 1
Zhengzhou 1
Totale 1.494
Salva come PNG Salva come JPEG
Nome #
Histamine mediates behavioural and metabolic effects of 3-iodothyroacetic acid, an endogenous end product of thyroid hormone metabolism 252
3-iodothyroacetic acid, a metabolite of thyroid hormone, induces itch and reduces threshold to noxious and to painful heat stimuli in mice 243
Stimulatory interactions between human coronary smooth muscle cells and dendritic cells 229
The pro-healing effect of exendin-4 on wounds produced by abrasion in normoglycemic mice 228
Pharmacologically active microcarriers for endothelial progenitor cell support and survival. 123
Characterization of circulating and monocyte-derived dendritic cells in obese and diabetic patients 116
The monocyte chemotactic protein synthesis inhibitor bindarit prevents mesangial cell proliferation and extracellular matrix remodeling 84
Exposure of cardiomyocytes to angiotensin II induces over-activation of monoamine oxidase type A: implications in heart failure 84
Stimulatory interactions between human coronary smooth muscle cells and dendritic cells 77
Interazioni fra cellule muscolari lisce vascolari e cellule dendritiche umane 56
The I{kappa}B Kinase Inhibitor Nuclear Factor-{kappa}B Essential Modulator-Binding Domain Peptide for Inhibition of Balloon Injury-Induced Neointimal Formation. 52
Human mature endothelial cells modulate peripheral blood mononuclear cells differentiation toward an endothelial phenotype 52
Studio del fenotipo delle cellule dendritiche di pazienti obesi ed insulino resistenti e della loro interazione con cellule muscolari lisce coronariche umane. 50
Microsfere biomimetiche farmacologicamente attive supportano la crescita e la sopravvivenza di cellule progenitrici endoteliali umane 50
Modulazione farmacologica delle interazioni fra cellule muscolari lisce vascolari e cellule dendritiche umane 40
The Ikb kinase inhibitor, nemo-binding domain peptide, inhibits rat balloon injury-induced neointimal formation 40
Effect of bindarit, a MCPs synthesis inhibitor, on mesangial cell dysfunction 38
Characterization of dendritic cells in obese and diabetic patients 36
Totale 1.850
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.729
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.729
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020371 31 41 11 28 40 34 37 42 30 35 38 4
2020/2021213 20 29 11 19 11 22 14 17 19 35 7 9
2021/2022137 9 16 11 8 3 4 10 6 5 7 16 42
2022/2023389 31 72 23 23 32 73 56 18 38 0 13 10
2023/2024131 6 10 21 9 9 16 4 31 11 0 9 5
2024/202534 34 0 0 0 0 0 0 0 0 0 0 0
Totale 1.850